Nagoya researchers find the neurons necessary for sustaining effort in rats — and that turning them up further does not buy more motivation.
Motivation is easier to describe than to locate. An animal deciding whether a reward is worth continued effort is doing something that must be implemented somewhere, and the obvious candidate — dopamine — has been studied so thoroughly that the interesting questions have moved to what else is involved.
A study in PNAS from Nagoya University puts a different population forward: orexin neurons, a small cluster in the hypothalamus best known for keeping animals awake. In rats, their activity tracks what reward is expected and how much work it will take, and suppressing them mid-anticipation makes an animal give up sooner.
The research was led by Hiroyuki Mizoguchi, an associate professor at the Nagoya University Graduate School of Medicine, with Kiyofumi Yamada, professor emeritus there, among the thirteen authors.
How you measure willingness to work
The behavioural tool is a progressive ratio test, and understanding it is most of understanding the result. A rat presses a lever for food, and the number of presses required climbs with each reward earned — five, then ten, then twenty, and so on. Eventually the animal stops. The point at which it stops is the breakpoint, and it is about as direct a measure of how much effort a reward is worth as behavioural neuroscience has.
Activating orexin neurons chemogenetically raised breakpoints: the rats worked harder. Degenerating them lowered breakpoints. That pairing establishes the population as relevant in both directions, which is more than a single manipulation would show.
The shape of the signal
The more informative data come from fibre photometry, which reports population activity continuously while an animal behaves. Three features stand out.
Orexin neuron activity rose before a reward was obtained and fell once it was received. It grew stronger as the required effort increased. And when an expected reward failed to arrive, activity stayed elevated.
That third pattern is the one worth dwelling on, because it distinguishes this signal from the canonical account of dopamine. Dopamine neurons are described as encoding reward prediction error: they fire above baseline when an outcome is better than expected and dip below it when an expected reward is omitted. Orexin neurons here do something closer to the opposite on omission — they keep going.
A signal that rises in anticipation, falls on delivery, scales with effort and persists when the reward does not come looks less like an error signal and more like a representation of an outstanding expectation: something is owed, and the animal has not been paid. That is the kind of signal useful for sustaining effort through a dry spell rather than for updating a prediction, and the two functions are complementary.
“Our study demonstrated significant changes in orexin neuron activity depending on expected rewards and the effort required,” Mizoguchi said.
Necessary, and not sufficient
The optogenetic experiments produced an asymmetry the authors are careful about.
Suppressing orexin neuron activity during reward anticipation slowed completion of the effort-based task and lowered breakpoints. Boosting activity at that same moment did not increase motivated behaviour further, even though the stimulation reliably activated the neurons.
The authors’ reading is that orexin neurons are necessary for sustaining motivated behaviour but that raising their activity alone may not be enough to increase it.
Asymmetries of this kind are common and informative. A system already operating near its ceiling in a well-motivated animal has nothing left to give when pushed, and a circuit that gates behaviour rather than driving it will show exactly this signature — remove it and performance collapses, add to it and nothing happens. The practical implication runs against the obvious one: a drug that activated orexin neurons would not necessarily make an unmotivated person motivated.
The sleep connection
Orexin, also called hypocretin, reached prominence through sleep rather than reward. Loss of orexin neurons causes narcolepsy type 1, and orexin receptor antagonists are now licensed insomnia treatments — which means there are already drugs in clinical use that act on this system, developed for an entirely different purpose.
That makes the motivational findings worth watching for a mundane reason. If orexin neurons are necessary for sustaining effort, the question of whether blocking orexin signalling nightly has daytime consequences for motivation is an empirical one, and this study does not address it. Nor should anything here be read as a reason to change a prescribed sleep medication.
The overlap also makes functional sense. An animal must be awake to work for food, and a system that registers an outstanding expectation of reward is well placed to keep an animal awake and pursuing it. Arousal and motivation are not separate problems from the hypothalamus’s point of view.
What the release does not report
The limits are substantial and mostly take the form of absent detail.
There are no numbers. The release reports no breakpoint values, no effect sizes, no sample sizes, no magnitude for any of the activity changes — its only figures are grant codes. Statements like “activity grew stronger as the required effort increased” describe a relationship whose steepness and reliability a reader cannot judge.
There is also only one quotation, and it is cut off mid-sentence on the page, which leaves the researchers’ own interpretation largely unreported.
The work is in rats, and the manipulations are the strengths and the weaknesses together. Chemogenetics and optogenetics give causal control that correlational recording cannot, at the cost of driving a population in ways it never fires naturally — synchronously, at experimenter-chosen moments, across a whole cell group. A result obtained by silencing a population during a one-second window is clean evidence about that population and not a description of how it ordinarily behaves.
Fibre photometry also reports the summed activity of many neurons rather than what individual cells do, so a uniform population signal and a mixture of differently tuned subpopulations can look the same.
The research was funded by Grants-in-Aid for Scientific Research (22K19749, 23K27360, 23H02669), AMED Japan (JP21wm0425014), and the SENSHIN Medical Research Foundation, Naito Foundation, Takeda Science Foundation, SRF, Asahi Glass Foundation, Mishima Kaiun Memorial Foundation and Kao Health Science Foundation. The paper was published on 29 June 2026; the release states no conflicts of interest.
Notes
- “Reward prediction is encoded by orexin neuron activity during motivated behavior.” Proceedings of the National Academy of Sciences, 2026. DOI: 10.1073/pnas.2520677123.
- Nagoya University. “The brain’s secret to staying motivated.” EurekAlert!, 3 August 2026. https://www.eurekalert.org/news-releases/1138157.
Jose Guzman / Jonas group at ISTA